Soligenix initiates clinical trial of its heat stable ricin toxin vaccine

Soligenix initiates clinical trial of its heat stable ricin toxin vaccine.soligenix inc - preliminary safety results from trial of heat stable ricin toxin vaccine are expected in q2 of 2020.soligenix - immunogenicity results from heat stable ricin toxin vaccine trial throughout 6-month follow-up period expected in q4 2020.
SNGX Ratings Summary
SNGX Quant Ranking